tirzepatide for ckd (Zepbound) showed improved kidney function in obese patients with both chronic kidney disease and #heartfailure with preserved ejection fraction, highlighting its potential to address this high-risk patient population. Read more: https Interplay of Chronic Kidney Disease

Even at the lower doses used for diabetes management (0.5-1 mg weekly), patients in the SUSTAIN clinical trials typically experienced 4-6 kg weight loss over 6-12 months

Your body, specifically your metabolism, is working against you

Chronic stress can alter gut motility and increase visceral hypersensitivityheightened awareness of normal digestive sensations

People who dont produce enough intrinsic factor can become deficient

Some people report noticing improvements in recovery, comfort, or mobility within a few weeks, while others may require a longer period before experiencing noticeable benefits

What will I learn